THROMBOLEX™, Inc. presented the prespecified interim analysis from the first 50 patients in RAPID-PE, a prospective, multicenter U.S. study evaluating On-The-Table (OTT) pharmaco-mechanical lysis (PML ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback